Table 1.
Baseline features of included studies in umbrella review of seroprevalence of Toxoplasma gondii and Quality assessment using the AMSTAR checklist
| Study/authors | Place of study | study group | Number of studies included in the meta-analysis | Population | %Seroprevalence, (95% CI) | % seroprevalence (95% CI) | Quality score | References | |
|---|---|---|---|---|---|---|---|---|---|
| IgM | IgG | ||||||||
| Mansouri et al. 2017 | Iran | Blood donor | 10 | 4538 | 31.84 (20.61-43.08) | 2.74 (0.55-4.92) | 34.4 (24.9-43.9) | 3 | [25] |
| Foroutan-Rad et al. 2016 | worldwide | Blood donor | 43 | 20964 | NA | 1.8 (1.1-2.4) | 33 (28-39) | 3 | [26] |
| Jiang et al. 2015 | china | Population with Cancer | 19 | 4493 | NA | NA | 20.59 (20.11-21.06) | 3 | [11] |
| Borna et al. 2013 | Iran | childbearing age women | 22 | 13480 | 34.5 (28.5-40.5) | NA | 39.9 (26.1-53.7) | 3 | [27] |
| Gebremedhin and Tadesse. 2015 | Etiopia | general population | 19 | 5718 | 74.73 (61.85-84.36) | NA | NA | 3 | [28] |
| Daryani et al. 2014 | Iran | general population | 35 | 52294 | NA | NA | 39.3 33-45.7 | 2 | [29] |
| Mizani et al. 2017 | Iran | childbearing age women | 38 | 17512 | 31 21-41 | 5 3.00-6.00 | 33 23-43 | 3 | [30] |
| Wang et al. 2017 | worldwide | HIV-infected | 74 | 25989 | NA | NA | 35.8 (30.8-40.7) | 3 | [31] |
| Foroutan et al. 2018 | Iran | hemodialysis patients | 10 | 1048 | 58 (46-70) | 2 (0-6) | NA | 3 | [32] |
| Ahmadpour et al. 2014 | Iran | immunocompromised patients | 22 | 2805 | NA | NA | 50.01 (43.85-56.17) | 1 | [33] |
| Wang et al. 2017 | worldwide | Immunocompromised patients | 72 | 17780 | NA | NA | 35.9 (31-40.8) | 3 | [34] |
| Foroutan et al. 2017 | Iran | general population | 117 | 105139 | NA | NA | 43 (38-47) | 3 | [35] |
| Ramirez et al. 2012 | Mexico | general population | 132 | 70123 | NA | NA | 19.27 (18.97-19.56) | 2 | [36] |
| Ramirez et al. 2012 | Mexico | Newborns and Children | 10 | 5728 | NA | NA | 3.63 (2.29-4.935) | 2 | [37] |
| Deng et al. 2017 | China | pregnant women | 72 | NA | 4.37 (2.22-8.1) | NA | NA | 2 | [38] |
| Malary et al. 2018 | Iran | pregnant women | 43 | 22644 | 39.2 (33.3-45.1) | 3.1-4.9 | 41.3 (35.8-46.8) | 3 | [39] |
| Wang et al. 2018 | China | Blood donor | 40 | 49784 | 6.26 (4.62-8.13) | NA | NA | 3 | [40] |
| Foroutan-Rad et al. 2016 | Iran | pregnant women | 50 | 20221 | 38 (34-42) | 4 (3-5) | 41 (36-45) | 3 | [41] |
| Hosseininejad et al. 2018 | worldwide | rheumatoid arthritis patients | 9 | 4168 | NA | NA | 46 (37-56) | 3 | [9] |
| Azadi et al. 2015 | Iran | pregnant women | 28 | 12818 | NA | NA | 34.2 (23-45.3) | 1 | [42] |
| Alzaheb. 2018 | Saudi Arabia | women of reproductive age | 20 | 13597 | NA | NA | 27.8 (20.6-36.3) | 2 | [43] |